Zikani Therapeutics

OverviewSuggest Edit

Zikani Therapeutics is a company that develops antibiotic compounds created to improve the lives of patients suffering from serious infections. Its macrolide antibiotics harness the power of synthetic chemistry and microbiology used in the treatment of gram-negative infections.
TypePrivate
Founded2015
HQWatertown, MA, US
Websitezikani.com

Latest Updates

Employees (est.) (Jan 2022)13
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Zikani Therapeutics

Sumit Aggarwal

Sumit Aggarwal

President and CEO
Roger Clark

Roger Clark

Vice President, Discovery Sciences
Vijay Modur

Vijay Modur

Head of R&D, Chief Scientific and Medical Officer
Dan Geffken

Dan Geffken

Chief Financial Officer
Alan Walts

Alan Walts

Executive Chairman
Show more

Zikani Therapeutics Office Locations

Zikani Therapeutics has an office in Watertown
Watertown, MA, US (HQ)
480 Arsenal Way #130
Show all (1)

Zikani Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2015

Zikani Therapeutics total Funding

$7.5 m

Zikani Therapeutics latest funding size

$7.5 m

Time since last funding

2 years ago

Zikani Therapeutics investors

Zikani Therapeutics's latest funding round in April 2020 was reported to be $7.5 m. In total, Zikani Therapeutics has raised $7.5 m
Show all financial metrics

Zikani Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Zikani Therapeutics Online and Social Media Presence

Embed Graph

Zikani Therapeutics News and Updates

Zikani Therapeutics Closes $7.5M Series A-1 Funding

Zikani Therapeutics, a Watertown, Mass.-based developer of novel ribosome modulating agents (RMAs) for the treatment of rare, nonsense mutation-driven diseases, closed a $7.5m Series A-1 financing. Backers included Advent Life Sciences, Gurnet Point Capital and Roche Venture Fund. The company wi…

Zikani Therapeutics Frequently Asked Questions

  • When was Zikani Therapeutics founded?

    Zikani Therapeutics was founded in 2015.

  • Who are Zikani Therapeutics key executives?

    Zikani Therapeutics's key executives are Sumit Aggarwal, Roger Clark and Vijay Modur.

  • How many employees does Zikani Therapeutics have?

    Zikani Therapeutics has 13 employees.

  • Who are Zikani Therapeutics competitors?

    Competitors of Zikani Therapeutics include Amarillo Biosciences, Haihe Biopharma and Sanofi Genzyme.

  • Where is Zikani Therapeutics headquarters?

    Zikani Therapeutics headquarters is located at 480 Arsenal Way #130, Watertown.

  • Where are Zikani Therapeutics offices?

    Zikani Therapeutics has an office in Watertown.

  • How many offices does Zikani Therapeutics have?

    Zikani Therapeutics has 1 office.